MYD88 and colorectal carcinoma: The most striking finding was the significantly higher TLR4 expression in CRC tissues (66.5% vs 30.5%, p<0.001), while MyD88 showed widespread expression in both groups with comparable overall positivity rates (CRC: 97.2%, adenoma: 95.4%).